Foghorn Therapeutics Inc.
FHTXNASDAQHealthcare● Active
$3.84
+$0.13(+3.50%)
Market Cap$225461376
P/E Ratio—
52W High$6.95
52W Low$3.27
Foghorn Therapeutics Inc. (FHTX) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FHTX · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $158.89M | $243.75M | $234.06M | $345.80M | $154.29M |
| Net Receivables | $0.00M | $0.00M | $0.00M | $0.00M | $300.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $163.24M | $249.60M | $240.18M | $351.40M | $459.56M |
| PP&E Net | $32.86M | $32.60M | $42.91M | $49.40M | $56.08M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $198.10M | $283.98M | $285.92M | $404.88M | $519.77M |
| Liabilities | |||||
| Short-Term Debt | $0.92M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $4.27M | $3.79M | $6.26M | $5.41M | $3.82M |
| Total Current Liabilities | $59.74M | $66.99M | $58.44M | $55.20M | $48.69M |
| Long-Term Debt | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $306.60M | $329.51M | $363.11M | $404.77M | $422.90M |
| Stockholders Equity | |||||
| Retained Earnings | ($632.47M) | ($558.18M) | ($471.56M) | ($373.14M) | ($264.26M) |
| Total Stockholders Equity | ($108.50M) | ($45.53M) | ($77.19M) | $0.11M | $96.87M |
| Total Liab & Equity(computed) | $198.10M | $283.98M | $285.92M | $404.88M | $519.77M |
| Debt Summary | |||||
| Total Debt | $41.27M | $37.13M | $45.07M | $51.51M | $58.33M |
| Net Debt | ($39.61M) | ($18.32M) | ($35.26M) | ($0.71M) | ($42.80M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Foghorn Therapeutics Inc. data
About Foghorn Therapeutics Inc. (FHTX) Balance Sheet
Foghorn Therapeutics Inc. (FHTX) balance sheet shows total assets of $0.20B with cash of $0.16B. Total liabilities are $0.31B, total debt $0.04B, and stockholders equity ($0.11B).
Frequently asked questions
FHTX · 4 questionsFoghorn Therapeutics Inc. has total debt of $0.04B with net debt of ($0.04B).
FHTX total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10